Statistics found here the category is Drug-related infectious diseases (INF)

Category	Title
INF	INF-1. AIDS incidence by year of diagnosis among injecting drug users by country, cases per million, 1998 to 2008
INF	INF-2. HIV infections newly diagnosed in injecting drug users, by country and year of diagnosis, cases per million, 2003–2008. EU countries, Croatia, Turkey and Norway. Part (i) HIV newly diagnosed cases per million population in IDUs, by year and by country — five highest EU countries in peak value 2003-2008
INF	INF-2. HIV infections newly diagnosed in injecting drug users, by country and year of diagnosis, cases per million, 2003–2008. EU countries, Croatia, Turkey and Norway. Part (ii) HIV newly diagnosed cases per million population in IDUs, by year and by country - other EU countries with peak > 1 case /M population 2003-2008
INF	INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (i) All injecting drug users, 2007 to 2008
INF	INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (ii) Young injecting drug users (under age 25), 2007 to 2008
INF	INF-3. HIV prevalence among injecting drug users — studies with national and subnational coverage Part (iii) New injecting drug users (injecting less than 2 years), 2007 to 2008
INF	INF-6. HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (i) All injecting drug users, 2007 to 2008
INF	INF-6. HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (ii) Young injecting drug users (under age 25), 2007 to 2008
INF	INF-6. HCV antibody prevalence among injecting drug users — studies with national and subnational coverage Part (iii) New injecting drug users (injecting less than 2 years), 2007 to 2008
INF	INF-9. Prevalence of markers of HBV infection estimated among injecting drug users — studies with national and subnational coverage Part (i) Percentage positive for ever infected (aHBc), 2007 to 2008
INF	INF-9. Prevalence of markers of HBV infection estimated among injecting drug users — studies with national and subnational coverage Part (ii) Percentage positive for current infection (HBsAg), 2007 to 2008
INF	INF-0. Bibliographic references
INF	INF-1. Prevalence of HIV infection among injecting drug users in the EU, 2008 or most recent year available — Summary table by country.
INF	INF-2. Prevalence of HCV antibody among injecting drug users in the EU, 2008 or most recent year available — Summary table by country.
INF	INF-3. Prevalence of markers for HBV infection among injecting drug users in the EU, 2008 or most recent year available — Summary table by country
INF	INF-104. HIV infections newly diagnosed and AIDS incidence among injecting drug users, by country and year of diagnosis Part (i) (a) cases per million population, (b) number of cases and (c) population sizes, 1993 to 2008
INF	INF-104. HIV infections newly diagnosed and AIDS incidence among injecting drug users, by country and year of diagnosis Part (ii) (a) AIDS incidence cases per million population, (b) number of cases and (c) population sizes, 1998 to 2008
INF	INF-105. Notified cases of hepatitis C infection among injecting drug users in the EU: a) Total number of cases where transmission route known, b) number of IDU cases, and c) percentage of IDUs amongst all cases with known risk factor
INF	INF-106. Notified cases of hepatitis B infection among injecting drug users in the EU: a) Total number of cases where transmission route known, b) number of IDU cases, and c) percentage of IDUs amongst all cases with known risk factor
INF	INF-107. Incidence studies of hepatitis C virus infection among injecting drug users in the EU
INF	INF-108. Prevalence of HIV infection among injecting drug users (%), 1991 to 2008
INF	INF-109. Prevalence of HIV infection among injecting drug users under age 25 (%), 1991 to 2008
INF	INF-110. Prevalence of HIV infection among new (injecting less than 2 years) injecting drug users (%), 1991 to 2008
INF	INF-111. Prevalence of hepatitis C infection among injecting drug users (%), 1991 to 2008
INF	INF-112. Prevalence of hepatitis C infection among injecting drug users under age 25 (%), 1991 to 2008
INF	INF-113. Prevalence of hepatitis C infection among new (injecting less than 2 years) injecting drug users (%), 1991 to 2008
INF	INF-114. Prevalence of current hepatitis B infection among injecting drug users (% with HBsAg), 1991 to 2008
INF	INF-115. Prevalence of antibodies against hepatitis B virus among injecting drug users (%), 1991 to 2008
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (i) Prevalence of HIV infection (percentage) among injecting drug users in prison
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (ii) Prevalence of hepatitis C infection (percentage) among injecting drug users in prison
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (iii) Prevalence of current hepatitis B infection (percentage with HBsAg) among injecting drug users in prison
INF	INF-117. Prevalence of HIV, HCV and HBV among drug users in prison, 1991 to 2008 Part (iv) Prevalence of antibodies against hepatitis B virus (percentage) among injecting drug users in prison